Caricamento...
Lessons from gefitinib-induced interstitial lung disease in Japan: Problems in approval, pharmacovigilance, and regulatory decision-making procedures
Objective: The objective of this study was to identifyproblems in the approval, pharmacovigilance, andpost-approval regulatory decision-makingprocedures involving gefitinib and to proposecountermeasures to prevent further drug-inducedsuffering in Japan in the future.Methods: We comprehensively revie...
Salvato in:
| Pubblicato in: | Pharmacy Practice |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Centro de investigaciones y Publicaciones Farmacéuticas
2006
|
| Soggetti: | |
| Accesso online: | https://www.redalyc.org/articulo.oa?id=69040404 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|